You are here Home Resources and guidance Sponsors Novartis Pharmaceuticals Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Australian public assessment report (AusPar) (1) Date 2021 (1) Search Sponsor content1 result(s) found, displaying 1 to 1 AusPAR: Ofatumumab 19 August 2021 Australian public assessment report (AusPar) Australian Public Assessment Report for Ofatumumab
AusPAR: Ofatumumab 19 August 2021 Australian public assessment report (AusPar) Australian Public Assessment Report for Ofatumumab